Data was analyzed with the CRO team continuing the 'blinded' structures concerning group assignment. The analysis team only had the Placebo group identified to them so that they would know how to organize the statistical comparisons. Only after the analysis was completed was the 'blind' broken in order to properly report relationships between the 3 different strengths of the product being tested and placebo.